Tiagabine early psychosis research study, Mass USA

This is a study on correcting abnormal brain development in early psychosis. It is in Massachusetts, US for ages 18-25 with recent onset.

The drug is an anti convulsive GABA reuptake inhibitor.

It’s a 6 month study as an add on to antipsychotics to see if it affects the long term outcome and functionality of people with sz.

2 Likes

Where have u been sister twinkle. … good to see u bank…good night sweet dreams…

1 Like

Really encouraging to see this being investigated. We were talking about gabaergic drugs being a candidate for treating unwanted thoughts weren’t we? Maybe this is the beginning of something great!

1 Like

Yeah, I’m feeling encouraged tonight, looking at the clinicaltrials.gov site. There are over 400 studies either recruiting or preparing to recruit, and they cover all kinds of drugs, therapies, biomarkers and diagnostics.

Everything from natural substances like curcumin, sulforaphane, and cannabidiol, to novel mechanisms like potassium channel modulators, deep brain stimulation, TMS, neurofeedback, cognitve training, cognitve training combined with drugs, cognitve training combined with exercise, development of biomarkers, genetic studies, you name it.

Tonight I just feel like there’s a lot of good efforts going on and not just bullsh.it music therapy for sz studies, lol.

Many of these will fail but there’s literally hundreds, some will work.

2 Likes